期刊文献+

胶质瘤组织中PTTG、MMP-2和Survivin的表达及意义 被引量:3

Expression and significance of PTTG,MMP-2 and Survivin in glioma
下载PDF
导出
摘要 目的:检测脑胶质瘤组织中PTTG、MMP-2和Survivin的表达情况并探讨其意义。方法:采用免疫组织化学SP法检测50例脑胶质瘤、10例正常脑组织中三者的表达情况。结果:脑胶质瘤组织中PTTG、MMP-2和Survivin表达定位于细胞浆,其阳性表达率分别为80.00%(40/50)、74.00%(37/50)和60.00%(30/50)与正常脑组织0、0和10%存在差异(P<0.05)。与胶质瘤患者的年龄、性别无明显相关性(P>0.05),但Ⅲ-Ⅳ组与Ⅰ-Ⅱ组之间表达有差异,具有统计学意义(P<0.05)。在脑胶质瘤组织中PTTG、MMP-2和Survivin的阳性表达呈正相关(P<0.05)。结论:PTTG、MMP-2和Survivin在脑胶质瘤组织中的表达情况,提示PTTG、MMP-2和Survivin高表达可能与胶质瘤发生有关,且与胶质瘤的浸润、发展、转移有关。 Objective:To determine the expression of PTTG,MMP-2 and Survivin in the glioma and the significance.Methods:Total of 50 cases of glioma and 10 cases of normal brain tissue were tested by immunohistochemistry SP.Results:The expressions of PTTG,MMP-2 and Survivin were located in cytoplasm.The positive expression rates were 80.00%(40 /50),74.00%(37 /50) and 60.00%(30 /50) respectively which were higher than that in normal brain tissue 0,0 and 10% respectively(P 0.05).There was no significant correlation with age,sex in glioma patients(P 0.05),but the expression was different statistically significant between Ⅲ-Ⅳ group and Ⅰ-Ⅱ group(P 0.05).The positive expression of PTTG,MMP-2 and Survivin were positively correlated in glioma.Conclusion:High expression of PTTG,MMP-2 and Survivin might be related with glioma,and were relevant to the invasion,development and metastasis.
机构地区 邯郸市第一医院
出处 《现代肿瘤医学》 CAS 2013年第8期1730-1732,共3页 Journal of Modern Oncology
基金 河北省科技厅计划项目基金(编号:11276103D-31)
关键词 脑胶质瘤 PTTG MMP-2 SURVIVIN 免疫组化 glioma PTTG MMP-2 Survivin immunohistochemistry
  • 相关文献

参考文献9

  • 1Weiler M,Wick W.Molecular predictors of outcome in low-grade glioma[J].Curr Opin Neurol,2012,25(6):767-773.
  • 2Chakravarti A,Delaney MA,Noll E,et al.Prognostic and pathologic significance of quantitative protein expression profiling in human gliomas[J].Clin Cancer Res,2001,7(8):2387-2395.
  • 3Pei L,Melmed S.Isolation and characterization of a pituitary tumor transforming gene(PTTG)[J].Mol Endocrinol,1977,11(4):433-441.
  • 4钟碧玲,彭辉,李亦明,王贵明,陈艳宇.PTTG和p53的表达与大肠癌淋巴结转移的关系[J].中国肿瘤,2011,20(7):534-537. 被引量:5
  • 5Kadoglou NP,Liapis CD.Maxtrix metalloproteinases:contribution to pathogesis diagnosis,surveillance and treatmeat of abdominal aortic aneurysms[J].Curr Med Res Opin,2004,20(4):419.
  • 6Shah FD,Shukla SN,Shah PM,et al.Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer[J].Indian J Cancer,2009,46(3):194-202.
  • 7Augello C,Caruso L,Maggioni M,et al.Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma[J].BMC Cancer,2009,(27):125-130.
  • 8Waligórska-Stachura J,Jankowska A,Wako R,et al.Survivin-prognostic tumor biomarker in human neoplasms-review[J].Ginekol Pol,2012,83(7):537-540.
  • 9Malik MT,Kakar SS. Regulation of angiongenesis and invasion by human pituitary tumor transforming gene(PTTG) through increased expression and secretion of matrix metalloproteinase-2(MMP-2)[J].Mol Cancer,2006,10(5):61.

二级参考文献13

  • 1Vlotides G, Eigler T, Melmed S. Pi- tuitary tumor-transforming gene: physiol- ogy and implications for tumorigenesis[J]. Endocr Rev, 2007, 28(2): 165-186.
  • 2Genkai N, Homma J, Sano M, et al. Increased expression of pituitary tumor- transforming genc (PTFG)-I is correlatedwith poor prognosis in glioma patients[J]. Oneol Rep, 2006, 15(6): 1569-1574.
  • 3Fujii T, Nomoto S, Koshikawa K, et al. Overexpression of pituitary tumor trans- forming gene 1 in HCC is associated with angiogenesis and poor prognosis [J]. Hepatology, 2006, 43(6): 1267-1275.
  • 4Kim DS, Franklyn JA, Smith VE, et al. Securin induces genetic instability in colorectal cancer by inhibiting dou- ble-stranded DNA repair activity[J]. Car- cinogenesis, 2007, 28(3): 749-759.
  • 5Yah S, Zhou C, Lou X, et al. PTFG overexpression promotes lymph node metastasis in human esophageal squa- mous cell carcinoma [J]. Cancer Res, 2009, 69(8): 3283-3290.
  • 6Hamid T, Kakar SS. FITG/securin activates expression of p53 and modu- lates its function [J]. Mol Cancer, 2004, 3: 18.
  • 7Solbach C, Roller M, Fellbaum C, et al. PTTG mRNA expression in prima- ry breast cancer: a prognostie marker for lymph node invasion and tumor recur- renee[J]. Breast, 2004, 13(1): 80-81.
  • 8Heaney A, Singson R, McCabe C, et al. Expression of pituitary-tumour transforming gene in eoloreetal tumours [J]. Lancet, 2000, 355(9205): 716-719.
  • 9Lane DP. Cancer p53, guardian of the genome[J]. Nature, 1992, 358(6381): 15-16.
  • 10Levine AJ, Finlay CA and Hinds PW. p53 is a tumor suppressor gene[J]. Cell, 2004, 116(2 Suppl): S67-S69.

共引文献4

同被引文献47

  • 1刘冬玲,李娜萍.MMP-14、VEGF、E-cadherin与子宫颈癌生物学行为的相关性研究[J].华中科技大学学报(医学版),2006,35(6):774-777. 被引量:9
  • 2张亚江,彭诗东.COX-2和CRIPTO-1在喉癌靶向治疗中的应用与展望[J].疾病监测与控制,2012,6(2):80-81. 被引量:1
  • 3刘业海,唐平章,刘芝华,徐震纲,祁永发,李爱东,丁芳,张立勇,骆爱萍.基质金属蛋白酶14基因在人喉鳞状细胞癌中表达差异的分析[J].中华耳鼻咽喉科杂志,2004,39(8):501-506. 被引量:7
  • 4韩韬,曲元明,牟成志,王韶光,胡佳.PCNA,PTTG在垂体瘤卒中的表达及与侵袭性的关系[J].山东大学学报(医学版),2006,44(4):380-383. 被引量:6
  • 5Cardoso E R, Peterson E W. Pituitary apoplexy: a review [J]. Neurosurgery, 1984, 14(3) :363-373.
  • 6Agrawal D, Mahapatra A K. Visual outcome of blind eye in pituitary apoplexy after transsphenoidal surgery: a series of 14 eyes[J]. Surgical Neurology, 2005, (63) :42- 46.
  • 7Biousse V, Newman N J, Oyesiku N M, et al. Precipitating factors in pituitary apoplexy [ J ]. J Neurol Neurosurg Psychiatry, 2001, 71 (4) :542-545.
  • 8Yang Y, Xuan J, Yang Z, et al. The expression of epi- dermal growth factor receptor and Ki-67 in primary and relapse nasopharyngeal cancer: a micro-evidence for anti- EGFR targeted maintenance therapy [J].Med Oncol, 2012, 29 ( 3 ) : 1448-1455.
  • 9Dowsett M, Smith I E, Ebbs S R, et al. Prognostic value of Ki-67 expression after short-term presurgical endocrine therapy for primary breast cancer[J].J Natl Cancer Inst, 2007, 99(2) : 167-170.
  • 10Proctor I, Stoeber K, Williams G H. Biomarkers in bladder cancer[J]. Histopathology, 2010, 57 ( 1 ) : 1-13.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部